You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

11C-UCB-J

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.

Not yet recruiting
  • Huntington Disease
  • [11C]UCB-J
  • [18F]SynVest-1
  • Leuven, Belgium
    UZ Leuven
Nov 2, 2022

Aberrant Synaptic Plasticity in Cocaine Use Disorder: A

Recruiting
  • Cocaine Use Disorder
  • Healthy Controls
  • 11C-UCB-J
  • New Haven, Connecticut
    Connecticut Mental Health Center
Aug 10, 2022

Alzheimer Trial in Lille, Paris, Rouen ([11C]-UCB-J, [18F]-DPA-714, [18F]-RO-948)

Not yet recruiting
  • Alzheimer Disease
  • [11C]-UCB-J
  • +3 more
  • Lille, France
  • +2 more
Jun 12, 2023

Cannabis Use Trial in New Haven ([11C]UCB-J PET)

Recruiting
  • Cannabis Use
  • [11C]UCB-J PET
  • New Haven, Connecticut
    Connecticut Mental Health Center
Aug 17, 2022

HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis Trial (SV2A PET, TSPO PET)

Not yet recruiting
  • HIV Associated Neurocognitive Disorder
  • +3 more
  • SV2A PET
  • TSPO PET
  • (no location specified)
Oct 16, 2022

Huntington Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-FDG PET-MR)

Active, not recruiting
  • Huntington Disease
  • 11C-UCB-J PET-CT
  • 18F-FDG PET-MR
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
May 18, 2022

Parkinson Disease Trial in Leuven (11C-UCB-J PET-CT, 18F-PE2I PET-MR)

Completed
  • Parkinson Disease
  • 11C-UCB-J PET-CT
  • 18F-PE2I PET-MR
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
May 18, 2022

Behavior, Health Trial in New Haven (Radiotracer)

Recruiting
  • Behavior, Health
  • New Haven, Connecticut
    Yale University PET Center
Jun 13, 2022

MDD Trial in Palo Alto, Stanford ([11C]UCB-J radiotracer, PET-MR)

Not yet recruiting
  • Major Depressive Disorder
  • [11C]UCB-J radiotracer
  • PET-MR
  • Palo Alto, California
  • +1 more
Sep 20, 2021

Schizophrenia Trial in Palo Alto, Stanford ([11C]UCB-J radiotracer, PET-MR)

Unknown status
  • Schizophrenia
  • [11C]UCB-J radiotracer
  • PET-MR
  • Palo Alto, California
  • +1 more
Nov 4, 2020

Opiate Dependence, Cocaine Dependence Trial in New Haven (11UCB-J PET Scan)

Recruiting
  • Opiate Dependence
  • Cocaine Dependence
  • 11UCB-J PET Scan
  • New Haven, Connecticut
    CT Mental Health Center
May 20, 2022

Precision Medicine in the Treatment of Epilepsy

Recruiting
  • Epilepsy
  • Copenhagen, Denmark
    Neurobiology Research Unit, Rigshospitalet
Jan 6, 2023

Healthy, Alzheimer Trial in Amsterdam, Groningen ([11C]-UCB-J)

Completed
  • Healthy
  • Alzheimer Disease
  • [11C]-UCB-J
  • Amsterdam, Netherlands
  • +2 more
Feb 19, 2020

Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)

Completed
  • Ketoses, Metabolic
  • Observational heart and kidney on siemens TEP scan
  • Sherbrooke, Quebec, Canada
    Research Center on Aging
Jan 16, 2023

Microglia in the Pathogenesis of Progressive Multiple Sclerosis

Active, not recruiting
  • Multiple Sclerosis
    • Turku, Finland Proper, Finland
      Turku PET Centre
    Oct 12, 2022

    Cannabis Use Disorder, Healthy Trial in New Haven ([11C]APP311)

    Recruiting
    • Cannabis Use Disorder
    • Healthy
    • New Haven, Connecticut
      Yale University School of Medicine
    Jul 20, 2022

    Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

    Active, not recruiting
    • Malignant Solid Neoplasm
    • Biopsy
    • +5 more
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Nov 15, 2023

    MDD Trial in New York (Ketamine)

    Completed
    • Major Depressive Disorder
    • New York, New York
      New York State Psychiatric Institute/Columbia University
    May 31, 2022

    Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue Trial (Red blood cell from umbilical cord blood, Red

    Not yet recruiting
    • Infant, Extremely Premature
    • +2 more
    • Red blood cell from umbilical cord blood
    • Red blood cell from adult donor
    • (no location specified)
    Nov 8, 2022

    Alzheimer Trial in Madison (UCB-J)

    Recruiting
    • Alzheimer Disease
    • Madison, Wisconsin
      University of Wisconsin
    Apr 27, 2022

    MDD, Anhedonia Trial in Saint Louis (Psilocybin)

    Withdrawn
    • Major Depressive Disorder
    • Anhedonia
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 26, 2023

    Lung Cancer Trial in Montréal (Patients with a living donor, Patients with a UCB donor)

    Active, not recruiting
    • Lung Cancer
    • Patients with a living donor
    • Patients with a UCB donor
    • Montréal, Quebec, Canada
      Hopital Sacre-Coeur
    Feb 14, 2021

    HIV Trial in Montreal (TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg), TN-C200M2 oral capsules (CBD 200 mg))

    Terminated
    • HIV Infections
    • TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg)
    • TN-C200M2 oral capsules (CBD 200 mg)
    • Montreal, Quebec, Canada
      Chronic Viral Illnesses Service, McGill University Health Centre
    Jun 26, 2022

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction Trial in Copenhagen (Treatment Package for First-Episode

    Recruiting
    • Depressive Disorder, Major
    • +4 more
    • Treatment Package for First-Episode Depression
    • Copenhagen, Denmark
      Neurobiology Research Unit, Rigshospitalet
    Nov 12, 2022